Freedom of Information
Statutory appointments
The Department is required to publish details of Statutory Appointments. This is a list of committees, panels or agencies employed under legislation to provide special services to the Department.
Health and Ageing Portfolio – List of Statutory Appointments
Downloadable PDF of List of statutory appointments (PDF 99 KB)
A. Departmental Bodies
B. Departmental Bodies Recognised in Legislation
C. Prescribed Agencies under the FMA Act
D. Commonwealth Authorities under the CAC Act
E. Statutory Corporations
F. Commonwealth Companies under the CAC Act
G. Other Companies
H. Other Entities
Type and Name of Body | Appointed By: | Constituted By: | Web Site | Responsible Division/Section | Act of Parliament under which Appointment was created |
|---|---|---|---|---|---|
A. Departmental Bodies |  | ||||
| National Pathology Accreditation Advisory Council | Minister for Health and Ageing appoints the members upon nominations from each of the represented jurisdictions and peak pathology organisations. | Chair, 11 nominees from professional pathology organisations and consumer organisations, and 9 representatives from the Commonwealth, States and Territories. | www.health.gov.au/npaac | Medical Benefits Division/ Pathology (Quality) Section | Subsection 9 (1) of the National Health Act 1953 – Constitution of the National Pathology Accreditation Advisory Council Order |
B. Departmental Bodies Recognised in Legislation | |||||
| Advisory Committee on Chemicals Scheduling (ACCS) | Appointed members are appointed by the Minister for Health and Ageing; nominated members are nominated by the Commonwealth, each State and Territory. | 9 members nominated by the Commonwealth, each State and Territory with a maximum of 6 “expert” appointed members, as defined in the Therapeutic Goods Regulations 1990. | www.tga.gov.au | Office of Health Protection/ Office of Chemical Safety and Environmental Health, Chemical Policy and Scheduling Secretariat Section | Section 52C of the Therapeutic Goods Act 1989 and regulations 42ZCS, 42ZCT and 42ZCU of the Therapeutic Goods Regulations 1990 |
| Advisory Committee on Complementary Medicines | Minister for Health and Ageing | Up to 12 appointed members with an expertise in 1 of the fields set out in subregulation 39B(2) of the Therapeutic Goods Regulations 1990. The field of expertise includes complementary medical practice, manufacture of medicines, consumer issues, general practice in Australia, herbal medicine, naturopathy etc. | www.tga.gov.au | Office of Complementary Medicines/Market Authorisation Group/ Therapeutic Goods Administration | Subregulation 39B(1)_of the Therapeutic Goods Regulations 1990 |
| Advisory Committee on Medical Devices | Minister for Health and Ageing | Up to 32 appointed members with an experise in 1 of the fields set out in subregulation 38B(2) of the Therapeutic Goods Regulations 1990. The field of expertise includes medical or surgical expertise in specified fields, manufacture of medical devices, consumer issues, biomedical engineering, biomaterials, and clinical medicine. | www.tga.gov.au | Committee Support Unit/ Office of Parliamentary and Strategic Support/ Regulatory Support Group/ Therapeutic Goods Administration | Subregulation 38B(1)_of the Therapeutic Goods Regulations 1990 |
| Advisory Committee on Medicines Scheduling (ACMS) | Appointed members are appointed by the Minister for Health and Ageing; nominated members are nominated by the Commonwealth, each State and Territory. | 9 members nominated by the Commonwealth, each State and Territory, with a maximum of 6 “expert” appointed members, as defined in the Therapeutic Goods Regulations 1990. | www.tga.gov.au | Office of Health Protection. Office of Chemical Safety and Environmental Health, Chemical Policy and Scheduling Secretariat Section | Section 52B and regulations 42ZCC, 42ZCD and 42ZCE of the Therapeutic Goods Regulations 1990. |
| Advisory Committee on Non-prescription Medicines | Minister for Health and Ageing | Up to 12 appointed members with an expertise in at least 1 of the fields set out in subregulation 36B(2) of the Therapeutic Goods Regulations 1990. The field of expertise includes general practice in Australia, pharmaceutical chemistry, pharmacology, toxicology, consumer issues, community pharmacy, etc. | www.tga.gov.au | Committee Support Unit/ Office of Parliamentary and Strategic Support /Regulatory Support Group/ Therapeutic Goods Administration | Subregulation 36B(1)_of the Therapeutic Goods Regulations 1990 |
| Advisory Committee on Prescription Medicines | Minister for Health and Ageing | Up to 25 appointed members with an expertise in at least 1 of the fields set out in subregulation 35B(2) of the Therapeutic Goods Regulations 1990. The field of expertise includes general practice in Australia, consumer issues, epidemiology or biostatistics, clinical pharmacology or pharmacokinetics, paediatrics, gerontology etc. | www.tga.gov.au | Committee Support Unit/Office of Parliamentary and Strategic Support/Regulatory Support Group/ Therapeutic Goods Administration | Subregulation 35B(1)_of the Therapeutic Goods Regulations 1990 |
| Advisory Committee on the Safety of Medicines | Minister for Health and Ageing | Up to 12 appointed members with an expertise in at least 1 of the fields set out in subregulation 37B(2) of the Therapeutic Goods Regulations 1990. The field of expertise includes pharmacoepidemiology, clinical pharmacology, clinical pharmacy, general medical practice in Australia, general medicine, consumer issues, etc. | www.tga.gov.au | Committee Support Unit/ Office of Parliamentary and Strategic Support /Regulatory Support Group/ Therapeutic Goods Administration | Subregulation 37B(1)_of the Therapeutic Goods Regulations 1990 |
| Aged Care Planning Advisory Committees | The members of a committee are to be appointed by the Secretary. | (1) A committee consists of a chairperson, a deputy chairperson and at least 6, and not more than 9, other members. (2) At least 2 members of a committee must be government officers. (3) At least 6 members of a committee (the non-government members) must not be government officers. | http://www.health.gov.au/internet/main/ publishing.nsf/Content/ageing-contacts-wg-wgindex.htm-copy2#3 | Convened separately in every state | Allocation Principles 1997, section 12 of the Aged Care Act 1997 |
| Australian Community Pharmacy Authority | Secretary of the Department appoints an official from the Department and the Minister for Health and Ageing appoints the other members. | 6 members, comprising an independent Chair, 2 pharmacists from the Pharmacy Guild of Australia, 1 pharmacist from the Pharmaceutical Society of Australia, a Departmental Officer and a person to represent the interests of the consumers | www.health.gov.au | Pharmaceutical Benefits Division /Pharmacy Location Rules Section | Section 99N of the National Health Act 1953 |
| Australian Sports Anti-Doping Authority Advisory Group | Minister for Sport | 2 to 7 members | No current website available | Population Health Division/Sport Branch | Australian Sports Anti Doping Authority Act 2006 |
| Complaints Resolution Panel | Chairman nominated by the Therapeutic Goods Advertising Code Council (TGACC), and other members are nominated by specified bodies | The Panel is to have 8 nominated members consisting of a Chairperson nominated by the TGACC, 2 members nominated by each of the CHCA and the ASMI, 2 consumer members nominated by specified bodies, and 3 healthcare professionals nominated by specified bodies. | www.tga.gov.au | Office of Product Review/Monitoring and Compliance Group / Therapeutic Goods Administration | Regulation 42T of the Therapeutic Goods Regulations 1990 |
| Therapeutic Goods Advertising Code Council (TGACC) | The Chairperson is appointed by the TGACC | TGACC consists of 15 members. The members consist of 5 manufacturer/supplier members nominated by specified bodies, 2 advertising industry members nominated by specified bodies, 2 consumer members nominated by specified bodies, 3 healthcare professional members nominated by specified bodies, 2 members nominated by the TGA and 1 member jointly nominated by the Australian Publishers Bureau and the Outdoor Advertising Association of Australia. | www.tga.gov.au | Office of Product Review/Monitoring and Compliance Group / Therapeutic Goods Administration | Regulation 42E of the Therapeutic Goods Regulations 1990 |
| Determining Authority (DA) | Minister for Health and Ageing appoints the Chairperson, medical practitioner member and non-practitioner member following consultation with the Australian Medical Association (AMA). Other practitioner members are appointed by the Minister following consultation with relevant professional bodies | Chairperson, a member who is not a practitioner, and eight other members representing the professional groups whose conduct may be reviewed under the PSR Scheme (medical and dental practitioners; participating optometrist; non-participating optometrist; chiropractor; physiotherapist; podiatrist; osteopath). | www.psr.gov.au | Medical Benefits Division /Medicare Benefits Branch/ Medicare Integrity Section Contact Person: Rosemund Ross (02) 6289 5460 | Part VAA Section 106ZPB of the Health Insurance Act 1973 |
| Gene Technology Technical Advisory Committee | Parliamentary Secretary to the Minister for Health and Ageing | 20 members including experts in relevant scientific fields including risk assessment, public health and ecology, as well as a layperson. The Committee also includes a person who is a member of the Gene Technology Ethics and Community Consultative Committee. The Gene Technology Act 2000 also provides that the Parliamentary Secretary may also appoint expert advisers to each of the committees (see ss102 & 112). Expert advisers are not considered members of the committee and may be appointed on a continuing or an ad hoc basis. | www.ogtr.gov.au | Office of Gene Technology Regulator | Gene Technology Act 2000 |
| Gene Technology Ethics and Community Consultative Committee | Parliamentary Secretary to the Minister for Health and Ageing | 12 members including experts in relevant fields including community consultation, risk communication, ethics, law and environmental issues. The Committee also includes a person who is a member of the Gene Technology Technical Advisory Committee and a person who is a member of the Australian Health Ethics Committee. The Gene Technology Act 2000 also provides that the Parliamentary Secretary may also appoint expert advisers to each of the committees (see ss102 & 112). Expert advisers are not considered members of the committee and may be appointed on a continuing or an ad hoc basis. | www.ogtr.gov.au | Office of Gene Technology Regulator | Gene Technology Act 2000 |
| General Practice Recognition Appeal Committee | Minister for Health and Ageing | 5 members (comprising two representatives from the Australian Medical Association, two from the Royal Australian College of General Practitioners, and one from the Australian Medical Council Limited) | No current web site available | Primary and Ambulatory Care Division Divisions Funding and Performance Section | Health Insurance (Vocational Registration of General Practitioners) Regulations 1989 |
| General Practice Recognition Eligibility Committee | Minister for Health and Ageing | 5 members (comprising two representatives from the Australian Medical Association, two from the Royal Australian College of General Practitioners, and one from the Australian Medical Council Limited) | No current web site available | Primary and Ambulatory Care Division Divisions Funding and Performance Section | Health Insurance (Vocational Registration of General Practitioners) Regulations 1989 |
| Health and Hospitals Fund Advisory Board | Minister for Health and Ageing | 7 members | www.health.gov.au/hhf | Portfolio Strategies Division/ Health & Hospitals Fund Taskforce | Nation-building Funds Act 2008 |
| Medical Training Review Panel | Minister for Health and Ageing | 32 members, comprising State and Territory representatives, officials representing medical colleges and other health stakeholders involved in education and training | www.health.gov.au | Health Workforce Division/ Medical Education and Training Branch Executive | Section 3GC - Health Insurance Act 1973 |
| Medicare Participation Review Committees | Minister for Health and Ageing | 3 members consisting of one Chair and two committee members | No current web site available | Medical Benefits Division /Medicare Benefits Branch/ Medicare Integrity Section Contact Person: Rosemund Ross (02) 6289 5460 | Part VB Section 124C of the Health Insurance Act 1973 |
| Pharmaceutical Benefits Advisory Committee | Minister for Health and Ageing | 12 to 18 members, 2/3 of whom must be from designated categories, with the remainder chosen for their expertise in the Committee’s work. | www.health.gov.au www.pbs.gov.au | PBAC Secretariat Section/ Pharmaceutical Evaluation Branch/ Pharmaceutical Benefits Division | Section 100B (1) of the National Health Act 1953 |
| Pharmaceutical Benefits Remuneration Tribunal | Governor-General appoints the Chair and the Minister for Health and Ageing may appoint four additional members not exceeding three years on a part-time basis. One of the additional members must be a person who has been, but is no longer, engaged either directly or indirectly in community pharmacy. Appointments made by the Minister for Health and Ageing follow consultation with the Pharmacy Guild of Australia. | Chair (a Deputy President of Fair Work Australia) and up to 4 other members | www.health.gov.au | Pharmaceutical Benefits Division /Community Pharmacy Branch/ Community Pharmacy Section | Section 98A of the National Health Act 1953 |
| Therapeutic Goods Committee | Minister for Health and Ageing | Up to 12 members, nominated to the Minister by a body that represents or a combination of bodies that together, represent the interests of 1 of the specified representative bodies. Members must have expertise in at least 1 of the following fields: microbiology and virology; biomedical engineering; biomedical engineering; biological safety of biomaterials; biotechnology; pharmaceutical science; community or hospital pharmacy practice. | www.tga.gov.au | Committee Support Unit/ Office of Parliamentary and Strategic Support/Regulatory Support Group/ Therapeutic Goods Administration | Subregulation 34B(1) of the Therapeutic Goods Regulations 1990 |
| Aged Care Commissioner | Minister for Health and Ageing | Aged Care Commissioner | www.agedcarecommissioner.net.au | Ageing and Aged Care Division / Office of Aged Care Quality and Compliance | Section 95A-1 of the Aged Care Act 1997 |
| Director of the National Industrial Chemicals Notification and Assessment Scheme | Governor-General | Director | www.nicnas.gov.au | Office of Health Protection / Office of Chemical Safety & Environmental Health | Industrial Chemicals (Notification and Assessment) Act 1989 Section 90 |
| Gene Technology Regulator | Governor-General | Gene Technology Regulator | www.ogtr.gov.au | Regulatory Policy and Governance Division /Research Regulation and Food Branch | Gene Technology Act 2000 |
| Professional Services Review – Director | Minister for Health and Ageing with the agreement of the Australian Medical Association | Director | www.psr.gov.au | Medical Benefits Division /Medicare Benefits Branch/ Medicare Integrity Section Contact Person: Rosemund Ross (02) 6289 5460 | Part VAA Division 2 Section 83 of the Health Insurance Act 1973 |
C. Prescribed Agencies under the FMA Act | |||||
| Australian Organ and Tissue Donation and Transplantation Authority | Parliamentary Secretary for Health appoints the CEO | Chief Executive Officer (CEO), Advisory Council and staff of the Authority | www.donatelife.gov.au | Regulatory Policy and Governance Division /Blood Organs and Regulatory Policy Branch | Australian Organ and Tissue Donation and Transplantation Authority Act 2008 |
| Australian Radiation Protection and Nuclear Safety Agency | The CEO of ARPANSA is appointed by the Governor-General | The Chief Executive Officer (CEO) of ARPANSA and the staff mentioned in section 58 | www.arpansa.gov.au | Regulatory Policy and Governance Division /Research Regulation and Food Branch | Australian Radiation Protection and Nuclear Safety (ARPANS) Act 1998 – Act No 133 of 1998 as amended |
| Australian Sports Anti-Doping Authority | Minister for Sport | Chief Executive Officer and staff, members of advisory committees, members of ASADA’s Advisory Group and members of the Anti-Doping Rule Violation Panel | www.asada.gov.au | Population Health Division/Sport Branch | Anti-Doping Rule Violation Panel appointed under Australian Sports Anti Doping Authority Act 2006 |
| National Blood Authority | Minister for Health and Ageing appoints the General Manager and the 7 members of the advisory board | The General Manager, the NBA Board, the staff and consultants | www.nba.gov.au | Regulatory Policy and Governance Division /Blood Organs and Regulatory Policy Branch | National Blood Authority Act 2003 |
| National Health and Medical Research Council | Minister for Health and Ageing appoints the CEO, Council, Principal Committees and Commissioner. | Chief Executive Officer (CEO), the Council, Principal Committees, Commissioner and staff | www.nhmrc.gov.au | Regulatory Policy and Governance Division /Research Regulation and Food Branch | National Health and Medical Research Council 1992 (NHMRC Act) |
| Professional Services Review | Minister for Health and Ageing appoints the Director with the agreement of the Australian Medical Association (AMA). Deputy Directors and PSR panel members are appointed by the Minister in consultation with the AMA (and other peak professional bodies for non-medical practitioners). | The Director of the Professional Services Review, the Deputy Directors, practitioners appointed to be members of the Panel, the staff mentioned in section 106ZM, persons whose services are made available to the Director under section 106ZN, and consultants engaged under section 106ZP. | www.psr.gov.au | Medical Benefits Division /Medicare Benefits Branch/ Medicare Integrity Section Contact Person: Rosemund Ross (02) 6289 5460 | Part VAA Division 2 Section 83 of the Health Insurance Act 1973 |
D. Commonwealth Authorities under the CAC Act | |||||
| Australian Institute of Health and Welfare | Governor-General appoints all members, on the nomination of the Minister for Health and Ageing, with the exception of the Director, who is appointed by the Minister for Health and Ageing. | Up to 15 members, including the Australian Statistician, the Secretary of the Department and an elected member of the Institute’s staff. | www.aihw.gov.au | Portfolio Strategies Division/ Economic and Statistical Analysis Branch | Australian Institute of Health and Welfare Act 1987 |
| Australian Sports Commission (Australian Institute of Sport) | Minister for Sport appoints all of the members with the exception of the Secretary of the Department who is a member ex officio. | Chair, Deputy Chair and 5 to 10 other members | www.ausport.gov.au | Population Health Division/Sport Branch | Australian Sports Commission Act 1989 |
| Food Standards Australia New Zealand | Minister for Health and Ageing appoints the members and the members appoint the Chief Executive Officer. | 11 members and the Chief Executive Officer | www.foodstandards.gov.au | Regulatory Policy and Governance Division /Research Regulation and Food Branch | Food Standards Australia New Zealand Act 1991 |
| Health Workforce Australia | Minister for Health and Ageing appoints all board members after nominations are received from the Commonwealth (which nominates 1 member), and from each State or Territory (which each nominates a member). All appointments are agreed to by the Australian Health Ministers’ Conference. | Chief Executive Officer (section 25), Board of Health Workforce Australia (section 8) and staff (sections 36 and 37) | www.hwa.gov.au | Health Workforce Division /Workforce Development Branch | Health Workforce Australia Act 2009 |
| Private Health Insurance Administration Council | The Chief Executive Officer is appointed by the Council. The Commissioner, Deputy Commissioner and three other members are appointed by the Minister for Health and Ageing. | Commissioner of Private Health Insurance Administration and 2 to 4 other members | www.phiac.gov.au | Medical Benefits Division /Private Health Insurance Branch/ Legal Policy Section | Section 264–1(1) Private Health Insurance Act 2007 |
E. Statutory Corporations (that are neither Commonwealth Authorities nor encompassed in an FMA Act Agency) | |||||
| Nil | | | | | |
F. Commonwealth Companies under the CAC Act | |||||
| Aged Care Standards and Accreditation Agency Ltd | Minister for Ageing | 6 to 15 directors | www.accreditation.org.au | Ageing and Aged Care Division / Office of Aged Care Quality and Compliance/ Accreditation Review & Policy Section | Aged Care Act 1997 |
| Australian Sports Foundation Limited | Minister for Sport | Up to 5 directors | www.asf.org.au | Population Health Division/Sport Branch | Australian Sports Commission Act 1985 |
G. Other Companies | |||||
| Nil | | | | | |
H. Other Entities | |||||
| Nil | | | | | |
Help with accessing large documents
When accessing large documents (over 500 KB in size), it is recommended that the following procedure be used:
- Click the link with the RIGHT mouse button
- Choose "Save Target As.../Save Link As..." depending on your browser
- Select an appropriate folder on a local drive to place the downloaded file
Attempting to open large documents within the browser window (by left-clicking)
may inhibit your ability to continue browsing while the document is
opening and/or lead to system problems.
Help with accessing PDF documents
To view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. A number of PDF readers are available through the Australian Government Information Management Office (AGIMO) Web Guide website.
